RxDoctor Payments Data

Jacob Schaeffer, MD

Surgery · Watertown, SDNPI 1790077022

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Organogenesis Inc. at 35.0% of the total. 2025 is the largest year on record at $212, 3.2 times the $66 reported in 2019. That places this record below the midpoint for surgery clinicians in SD, where the typical reported total is $829.

$405in general payments, 2019–2025

Across 15 payments — averaging $26.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$141
  • Pacira Pharmaceuticals Incorporated$66
  • TELA Bio, Inc.$40
  • Johnson & Johnson$38
  • Phathom Pharmaceuticals, Inc.$29
  • Polynovo North America LLC$28
  • plus $62 from 3 others

What the payments were for

  • Food & beverage$405100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405 in reported general payments places this provider in the 40th percentile of 87 surgery providers in South Dakota.

See all surgery providers in South Dakota

Medicare billing

Part B allowed, 2024
$141,226
Medicare patients
382
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl125$2,116
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl20$328
Omeprazole16$165
Oxycodone Hcl58$99
Metronidazole11$20

Paid to pharmacies, not to this prescriber.

Other surgery in Watertown

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →